Pharma & Biotech

After a significant downturn in August, CSL's stock is demonstrating encouraging signs of a rebound. The biotechnology company's shares have...

Biotechnology firm Replimune witnessed a dramatic surge in its share price following a significant regulatory development. The substantial upward movement,...

Investor attention is turning to TG Therapeutics as the biopharmaceutical company demonstrates compelling signals that could indicate future strength. Recent...

Bayer shareholders face renewed pressure as another court ruling delivers a substantial blow. A $600 million damages award has been...

Viking Therapeutics stands at a pivotal moment in its corporate trajectory. The biotechnology firm has initiated a new maintenance study...

The biotechnology sector is witnessing remarkable momentum in Assembly Biosciences stock, which has now advanced for six consecutive trading sessions....

Alnylam Pharmaceuticals continues its impressive market performance, consistently reaching new valuation heights. However, this upward trajectory hasn't convinced all market...

Institutional investors are demonstrating significant confidence in Sarepta Therapeutics through recent strategic moves. Privium Fund Management B.V. established a new...

The biotechnology sector is witnessing the emergence of a formidable player as Arrowhead Pharmaceuticals capitalizes on a landmark collaboration with...

The biotechnology sector has witnessed the emergence of a standout performer: Ocugen. This gene therapy enterprise is demonstrating remarkable momentum,...